MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 3.95 HKD 1.28% Market Closed
Updated: May 31, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

212.5m
+22%
Revenue
Jun 30, 2023 212.5m
Dec 31, 2022 173.5m
-91.3m
+23%
Operating Income
Jun 30, 2023 -91.3m
Dec 31, 2022 -117.9m
-45.8m
-31%
Net Income
Jun 30, 2023 -45.8m
Dec 31, 2022 -35m

Earnings Waterfall
MicroTech Medical Hangzhou Co Ltd

Revenue
212.5m CNY
Cost of Revenue
-107.7m CNY
Gross Profit
104.8m CNY
Operating Expenses
-196.1m CNY
Operating Income
-91.3m CNY
Other Expenses
45.5m CNY
Net Income
-45.8m CNY

Income Statement
MicroTech Medical Hangzhou Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2022 Jun-2023
Revenue
Revenue
174
N/A
213
+22%
Gross Profit
Cost of Revenue
(94)
(108)
Gross Profit
80
N/A
105
+32%
Operating Income
Operating Expenses
(198)
(196)
Selling, General & Administrative
(159)
(197)
Research & Development
(58)
(69)
Depreciation & Amortization
(3)
0
Other Operating Expenses
23
70
Operating Income
(118)
N/A
(91)
+23%
Pre-Tax Income
Interest Income Expense
86
50
Non-Reccuring Items
(3)
(4)
Total Other Income
0
(0)
Pre-Tax Income
(35)
N/A
(46)
-31%
Net Income
Tax Provision
0
0
Income from Continuing Operations
(35)
(46)
Net Income (Common)
(35)
N/A
(46)
-31%
EPS (Diluted)
-0.08
N/A
-0.11
-38%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.